Log in

NASDAQ:RARXRa Pharmaceuticals Earnings Date, Estimates & History

$47.99
0.00 (0.00 %)
(As of 04/2/2020)
Add
Compare
Today's Range
$47.99
Now: $47.99
$47.99
50-Day Range
$47.99
MA: $47.99
$48.00
52-Week Range
$19.64
Now: $47.99
$48.02
Volume30,200 shs
Average Volume1.16 million shs
Market Capitalization$2.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05

Earnings

Ra Pharmaceuticals (NASDAQ:RARX) Earnings Information

Ra Pharmaceuticals last released its earnings data on February 27th, 2020. The reported ($0.79) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.63) by $0.16. Ra Pharmaceuticals has generated ($2.31) earnings per share over the last year.

Ra Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Ra Pharmaceuticals (NASDAQ:RARX) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.61)($0.61)($0.61)
Q2 20201($0.66)($0.66)($0.66)

Ra Pharmaceuticals (NASDAQ RARX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/27/2020Q4 2019($0.63)($0.79)($0.79)N/A
11/7/2019Q3($0.5030)($0.55)($0.55)$3.00 millionN/A
8/7/2019Q2 2019($0.49)($0.52)($0.52)N/A
5/9/20193/31/2019($0.47)($0.45)($0.45)N/A
3/7/201912/31/2018($0.49)($0.47)($0.47)$2.50 million$2.50 millionN/A
11/7/2018Q3($0.4920)($0.51)($0.51)N/A
8/8/2018Q2 2018($0.50)($0.49)($0.49)N/A
5/9/2018Q1 2018($0.5570)($0.61)($0.61)N/A
3/14/2018Q4 2017($0.6970)($0.67)($0.67)N/A
11/9/2017Q3 2017($0.62)($0.68)($0.68)N/A
8/9/2017Q2 2017($0.4950)($0.56)($0.56)N/A
5/11/2017Q1 2017($0.5820)($0.50)($0.50)N/A
3/6/2017Q4 2016($0.44)($0.73)($0.73)N/A
11/29/2016Q3 2016($0.50)($14.22)($14.22)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.